Warning letterFDA · Feb 16, 2021
KDunn and Associates, P.A. dba HealthQuilt MARCS-CMS 611864, February 16, 2021
Named company: KDunn and Associates, P.A. dba HealthQuilt
The investigational drug (b)(4) used in the study was an unapproved new drug, administered to human subjects (b)(4) for (b)(4) to treat, cure, and prevent COVID-19. (b)(4) is not a lawfully marketed drug…
